Tactive Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,134
Closed -$368K 258
2025
Q3
$368K Sell
23,134
-385,312
-94% -$6.35M 0.1% 175
2025
Q2
$7.23M Buy
+408,446
New +$7.96M 2.34% 7
2024
Q1
$12.6M Buy
701,236
+104,382
+17% +$1.89M 6.72% 2
2023
Q4
$10.1M Buy
+596,854
New +$11.9M 6.51% 4

Other funds holding BTAL

Tactive Advisors's BTAL Position: Q4 2025 in Review

Tactive Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 23,134 shares — an estimated $368K sold.

Tactive Advisors first reported a position in BTAL in Q4 2023 and held it in 4 quarters. The position peaked at $12.6M in Q1 2024. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

  • Tactive Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
  • Tactive Advisors sold 23,134 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $368K.
  • Tactive Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and held it in 4 quarters.
  • Tactive Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $12.6M in Q1 2024.
  • 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on Tactive Advisors's 13F filing for Q4 2025, filed 9 Jan 2026.